Sentrex Health Solutions Inc., a prominent Canadian specialty healthcare service provider, announced the acquisition of PerCuro Clinical Research Ltd., a leading provider of infusion services, clinical research, and advanced nursing care in Canada. This acquisition is a key development in Sentrex's goal to expand innovative healthcare offerings nationwide.

PerCuro, established in 2003 and known for its nurse-led care model, plays a crucial role in delivering vital medical services in various therapeutic areas, including inflammatory bowel disease, neurology, and rare diseases, primarily on Vancouver Island. Leeanna Bulinckx, PerCuro's Founder & CEO, expressed enthusiasm for joining Sentrex, highlighting the potential to extend PerCuro's model beyond Vancouver Island with Sentrex's support, emphasizing patient care alignment.

Dr. Kevin Rioux, a gastroenterologist, praised PerCuro's nurse-led model for enhancing patient care quality and accessibility. Taflyn Hornibrook, CEO of Sentrex, emphasized the strategic fit of PerCuro within Sentrex's expansion goals, particularly in infusion and nursing services, underscoring a shared commitment to exceptional patient care and outcomes.

The transaction aims to maintain seamless care throughout the integration, ensuring continued high-quality service for patients and stakeholders. However, the summary does not include the transaction value or legal advisors involved, which were not mentioned in the provided article excerpt.